Molecular Partners Announces Publication in Cancer Immunolog

Preclinical data of tetra-specific T cell engager MP0533 demonstrate preferential T cell mediated killing of AML cells, while sparing healthy cellsResults highlight MP0533-mediated T-cell activation...

Related Keywords

Zurich , Züsz , Switzerland , United States , Bern , Massachusetts , American , Seth Lewis , Laura Jeanbart , University Of Bern , Cancer Immunology Research , Linkedin , American Association For Cancer Research , Head Of Portfolio Management Communications , Exchange Commission , American Society Of Hematology , Nasdaq , American Association , Cancer Research The , American Society , Annual Meeting , Selectivet Cell , Mediated Killing , Immunol Res , Designed Ankyrin Repeat Protein , Portfolio Management , Private Securities Litigation Reform Act , Molecular Partner , Risk Factors , Molecular Partner Annual Report , Molecular Partners , Markets ,